Ringerlactat B. Braun (nach Hartmann)

Ringerlactat B. Braun (nach Hartmann) is a medicine authorised by Swissmedic under authorisation number 38207. The authorisation holder is B. Braun Medical AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 23 April 1974 and the authorisation is valid without a time limit. ATC code B05BB01 places the medicine in the group Blood substitutes and perfusion solutions.

Dispensing category B
Authorisation number 38207
ATC B05BB01
Synthetic medicines

Authorisation data
Authorisation number	38207
Name	Ringerlactat B. Braun (nach Hartmann)
Full name	Ringerlactat B. Braun (nach Hartmann), Infusionslösung
Authorisation holder	B. Braun Medical AG
Medicinal product code	Synthetic medicines
Dispensing category	B · Prescription only
ATC code	B05BB01
First authorisation	23 April 1974
Authorisation validity	unlimited

Strengths
No.	Name	Dispensing category	Authorisation date
1	Ringerlactat B. Braun (nach Hartmann), Infusionslösung	B	23 April 1974
2	Ringerlactat Glucose B. Braun (nach Hartmann), Infusionslösung	B	09 February 1988

Scroll the table sideways

Pack sizes
Pack code	Quantity	Unit	ATC	IT code	Dispensing category
237	20 x 250	ml	B05BB01	05.03.3.	B
245	20 x 500	ml	B05BB01	05.03.3.	B
253	10 x 1000	ml	B05BB01	05.03.3.	B
296	10 x 500	ml	B05BB01	05.03.3.	B
326	10 x 1000	ml	B05BB01	05.03.3.	B
327	1 x 500	ml	B05BB01	05.03.3.	B
328	1 x 1000	ml	B05BB01	05.03.3.	B
261	20 x 250	ml	B05BB01	05.03.3.	B
288	10 x 1000	ml	B05BB01	05.03.3.	B

Scroll the table sideways

Medicines in the same ATC group

Hylvastam 14 mg/mlAuthorisation number 69932 · Leman SKL SA · ATC B05BB01B NaCl 0Authorisation number 42425 · Fresenius Kabi (Schweiz) AG · ATC B05BB01B NaCl 0Authorisation number 52041 · Sintetica SA · ATC B05BB01B NaCl 0Authorisation number 56540 · Sintetica SA · ATC B05BB01B NaCl 0.9 % AApotAuthorisation number 60300 · Armeeapotheke · ATC B05BB01B NaCl 0.9 % B. BraunAuthorisation number 29554 · B. Braun Medical AG · ATC B05BB01B NaCl 0.9 % FreseniusAuthorisation number 53772 · Fresenius Kabi (Schweiz) AG · ATC B05BB01B Natrium Bicarbonicum Bichsel 8.4 %Authorisation number 36797 · Laboratorium Dr. G. Bichsel AG · ATC B05BB01B Natrium chloratum 0Authorisation number 56508 · Amino AG, Fabrikation pharmazeutischer und chemischer Produkte · ATC B05BB01B Natrium chloratum Bichsel 0Authorisation number 29800 · Laboratorium Dr. G. Bichsel AG · ATC B05BB01B Natriumchlorid 0Authorisation number 41181 · Baxter AG · ATC B05BB01B Plasma-Lyte AAuthorisation number 56078 · Baxter AG · ATC B05BB01B

Other medicines from this authorisation holder

Aqua ad iniectabilia B. BraunAuthorisation number 45794 · ATC V07ABB Braunoderm ungefärbtAuthorisation number 43468 · ATC D08AX05D BraunolAuthorisation number 43469 · ATC D08AG02D BraunovidonAuthorisation number 43557 · ATC D08AG02D Duosol 2 mmol/l KAuthorisation number 65637B Duosol 4 mmol/l KAuthorisation number 65638B Duosol ohne KAuthorisation number 65600B Etomidat-LipuroAuthorisation number 52303 · ATC N01AX07B

Frequently asked questions

Is Ringerlactat B. Braun (nach Hartmann) authorised in Switzerland?

Yes. Ringerlactat B. Braun (nach Hartmann) is authorised by Swissmedic under authorisation number 38207, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Ringerlactat B. Braun (nach Hartmann) have?

Ringerlactat B. Braun (nach Hartmann) is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Ringerlactat B. Braun (nach Hartmann)?

The authorisation holder is B. Braun Medical AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.